A Study to Test if Fremanezumab Reduces Headache in Participants With Posttraumatic Headache (PTH)
Public ClinicalTrials.gov record NCT03347188. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Multicenter, Randomized, Proof-of-Concept, Double-Blind, Placebo-Controlled, Parallel-Group Study, Including an Open-Label Period, Evaluating the Efficacy and Safety of 1 Subcutaneous Dose Regimen of Fremanezumab for the Treatment of Posttraumatic Headache (PTH)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a multicenter, randomized, double-blind, placebo-controlled, parallel-group study to evaluate the safety and efficacy of fremanezumab in adult participants aged 18 to 70 years, inclusive, for the prevention of PTH. The study will include a double-blind (DB) treatment period (12 weeks) and an open-label (OL) treatment period (12 weeks).
Study identification
- NCT ID
- NCT03347188
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 87 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 70 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 18, 2017 (Actual)
- Primary completion
- Mar 13, 2020 (Actual)
- Completion
- Jun 3, 2020 (Actual)
- Last update posted
- Dec 13, 2022
2017 – 2020
United States locations
- U.S. sites
- 33
- U.S. states
- 18
- U.S. cities
- 32
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Teva Investigational Site 14065 | Phoenix | Arizona | 85018 | — |
| Teva Investigational Site 14069 | Scottsdale | Arizona | 85259-5452 | — |
| Teva Investigational Site 14048 | Little Rock | Arkansas | 72205 | — |
| Teva Investigational Site 30236 | Little Rock | Arkansas | 72205 | — |
| Teva Investigational Site 14052 | Long Beach | California | 90806 | — |
| Teva Investigational Site 14053 | Los Angeles | California | 90073 | — |
| Teva Investigational Site 14060 | San Diego | California | 92161 | — |
| Teva Investigational Site 14054 | San Francisco | California | 94109 | — |
| Teva Investigational Site 14045 | Fairfield | Connecticut | 06824 | — |
| Teva Investigational Site 14063 | Miami | Florida | 33136 | — |
| Teva Investigational Site 14041 | North Miami | Florida | 33161 | — |
| Teva Investigational Site 14056 | Tampa | Florida | 33609 | — |
| Teva Investigational Site 14057 | Riverwoods | Illinois | 60015 | — |
| Teva Investigational Site 14067 | Indianapolis | Indiana | 46256 | — |
| Teva Investigational Site 14058 | Louisville | Kentucky | 40207 | — |
| Teva Investigational Site 14061 | Waltham | Massachusetts | 02451 | — |
| Teva Investigational Site 14051 | Kansas City | Missouri | 64128-2226 | — |
| Teva Investigational Site 14043 | Springfield | Missouri | 65810 | — |
| Teva Investigational Site 14046 | St Louis | Missouri | 63141 | — |
| Teva Investigational Site 14119 | Albany | New York | 12208 | — |
| Teva Investigational Site 14229 | Amherst | New York | 14226 | — |
| Teva Investigational Site 14047 | New York | New York | 10021 | — |
| Teva Investigational Site 14118 | The Bronx | New York | 10467 | — |
| Teva Investigational Site 14114 | Durham | North Carolina | 27713 | — |
| Teva Investigational Site 14059 | Salisbury | North Carolina | 28144 | — |
| Teva Investigational Site 14049 | Portland | Oregon | 97225 | — |
| Teva Investigational Site 14064 | Philadelphia | Pennsylvania | 19107 | — |
| Teva Investigational Site 14040 | Pittsburgh | Pennsylvania | 15236 | — |
| Teva Investigational Site 14230 | Nashville | Tennessee | 37203 | — |
| Teva Investigational Site 14055 | Dallas | Texas | 75390-8565 | — |
| Teva Investigational Site 14050 | Waco | Texas | 76711 | — |
| Teva Investigational Site 14113 | Spokane | Washington | 99202 | — |
| Teva Investigational Site 14044 | Morgantown | West Virginia | 26506 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03347188, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 13, 2022 · Synced Oct 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT03347188 live on ClinicalTrials.gov.